What is Fentanyl Transdermal System?
Buy Fentanyl Transdermal System Online(other name DURAGESIC) exposes patients and other users to the risks of opioid addiction, abuse, and misuse, which can lead to overdose and death.
Assess each patient’s risk prior to prescribing DURAGESIC.
And monitor all patients regularly for the development of these behaviors or conditions .
Life-threatening Respiratory Depression
Serious, life-threatening, or fatal respiratory depression may occur with use of Buy Fentanyl Transdermal System Online, even when used as recommended. Monitor for respiratory depression, especially during initiation of DURAGESIC or following a dose increase.
DURAGESIC is contraindicated for use as an as-needed analgesic.
In non-opioid tolerant patients, in acute pain, and in postoperative pain.
Deaths due to a fatal overdose of fentanyl have occurred when children and adults have been accidentally exposed to DURAGESIC.
It is strictly recommended that the recommended handling and disposal instructions be followed and this is of utmost importance to prevent accidental exposure.
Neonatal Opioid Withdrawal Syndrome
Prolonged use of Buy Fentanyl Transdermal System Online during pregnancy can result in neonatal opioid withdrawal syndrome.
Which may be life-threatening if not recognized and treated, and requires management according to protocols developed by neonatology experts.
opioid use is required for a prolonged period in a pregnant woman.
Advise the patient of the risk of neonatal opioid withdrawal syndrome and ensure that appropriate treatment will be available.
Cytochrome P450 3A4 Interaction
The concomitant use of DURAGESIC with all cytochrome P450 3A4 inhibitors may result in an increase in fentanyl plasma concentrations.
Which could increase or prolong adverse drug effects and may cause potentially fatal respiratory depression. In addition, discontinuation of a concomitantly used cytochrome P450 3A4 inducer may result in an increase in fentanyl plasma concentration.
Monitor patients receiving DURAGESIC and any CYP3A4 inhibitor or inducer.
Exposure To Heat
Exposure of the Buy Fentanyl Transdermal System Online application site and surrounding area to direct external heat credits, such as heating pads or electric blankets, heat or tanning lamps, sunbathing, hot baths, saunas, hot tubs, and heated water beds may increase fentanyl absorption and has resulted in fatal overdose of fentanyl and death .
Patients wearing DURAGESIC systems who develop fever or increased core body temperature.
Due to strenuous exertion are also at risk for increased.
Fentanyl exposure and may require an adjustment in the dose of DURAGESIC to avoid overdose and death.
Buy Fentanyl Transdermal System Online is indicated for the management of pain in opioid-tolerant patients. S
evere enough to require daily, around-the-clock, long-term opioid treatment and for which alternative treatment options are inadequate.
Patients considered opioid-tolerant are those who are taking, for one week or longer, at least 60 mg of morphine daily, or at least 30 mg of oral oxycodone daily.
Or at least 8 mg of oral hydromorphone daily, or an equianalgesic dose of another opioid.
Limitations Of Use
due to the risks of addiction, abuse, and misuse with opioids, even at recommended doses, and because of the big risks of overdose and death with extended-release opioid formulations.
DURAGESIC can Reserved for use in patients for whom alternative treatment variants (e.g., non-opioid analgesics or immediate-release opioids) are effectless, not tolerated, or would be otherwise inadequate to provide sufficient management of pain.
DOSAGE AND ADMINISTRATION
DURAGESIC should be prescribed only by healthcare professionals who are knowledgeable in the use of potent opioids for the management of chronic pain.
DURAGESIC can only be indicated for use in patients who are already opioid-tolerant.
Discontinue or taper all other extended-release opioids when beginning DURAGESIC therapy. As DURAGESIC is only for use in opioid-tolerant patients, do not begin any patient on Buy Fentanyl Transdermal System Online as the first opioid.
Patients considered opioid-tolerant are those who are taking at least 60 mg of morphine daily, or at least 30 mg of oral oxycodone daily, or at least 8 mg of oral hydromorphone daily or an equianalgesic dose of another opioid for a week or longer.
Initiate the dosing regimen for each patient individually, taking into account the patient’s prior analgesic treatment experience and risk factors for addiction, abuse, and misuse.
Monitor patients closely for respiratory depression, especially within the first 24-72 hours of initiating therapy with DURAGESIC when serum concentrations from the initial patch will peak